Report ID: UCMIG35D2008
Report ID:
UCMIG35D2008 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
The market for treating inflammatory bowel disease was worth USD 23.90 billion in 2021, and it is expected to increase from USD 25.18 billion in 2022 to USD 37.00 billion by 2029, with a CAGR of 5.7% throughout the forecast period. In 2020, the market's growth was slower at 4.7% compared to 2019. The global COVID-19 pandemic has had an unprecedented and significant impact, causing a lower-than-expected demand for inflammatory bowel disease treatment worldwide when compared to pre-pandemic levels.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Services by segment aggregation, the contribution of the Health Care Services in Health Care Equipment & Services and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Inflammatory Bowel Disease Treatment was estimated to be valued at US$ XX Mn in 2021.
The Inflammatory Bowel Disease Treatment Market is estimated to grow at a CAGR of XX% by 2028.
The Inflammatory Bowel Disease Treatment Market is segmented on the basis of Disease Indication, Route of Administration, Drug Class, Distribution Channel, regions.
Based on region, the Inflammatory Bowel Disease Treatment Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Inflammatory Bowel Disease Treatment Market are AbbVie Inc. (U.S.), Takeda Pharmaceutical Company Limited (Tokyo), UCB S.A. (Belgium), Bausch Health Companies Inc. (Canada), Bristol-Myers Squibb Company (U.S.), Pfizer Inc. (U.S.), CELLTRION INC. (South Korea), Johnson & Johnson Services, Inc. (U.S.).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35D2008